Instrument Inactif

Cours Abraxis Bioscience, Inc.

Actions

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

ABRAXIS BIOSCIENCE : Celgene va acquérir Abraxis BioScience Inc.	30/06/10	BU
ABRAXIS BIOSCIENCE : lance Abraxane® dans l'Union Européenne	16/12/08	BU
Abraxis Bioscience : La Commission européenne accorde à Abraxis l'autorisation de mise sur le marché d'ABRAXANE pour le traitement du cancer du sein métastatique en Europe	22/01/08	BU

ABRAXIS BIOSCIENCE : Celgene and Abraxis Announce Shareholder Vote in Favor of Merger	13/10/10
ABRAXIS BIOSCIENCE : and Specialised Therapeutics Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in New Zealand	29/07/10
ABRAXIS BIOSCIENCE : ABRAXANE® Approved for Marketing in Japan for Breast Cancer	23/07/10
ABRAXIS BIOSCIENCE : The Law Office of Joseph Klein Investigates Possible Breach of Fiduciary Duty by the Board of Abraxis BioSciences Inc. - ABII	08/07/10
ABRAXIS BIOSCIENCE : Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of Abraxis BioScience, Inc.	01/07/10

Secteur